The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

The Effect of Thalidomide on Entero-Behcet's Disease

장관 베체트병 환자에서 Thalidomide의 치료 효과

  • Kim, Jung Hak (Department of Anesthesiology and Pain Medicine, St. Mary's Hospital, The Catholic University of Korea College of Medicine) ;
  • Nam, Voki (Department of Anesthesiology and Pain Medicine, St. Mary's Hospital, The Catholic University of Korea College of Medicine) ;
  • Moon, Ho Sik (Department of Anesthesiology and Pain Medicine, St. Mary's Hospital, The Catholic University of Korea College of Medicine) ;
  • Kim, Jin Ook (Department of Anesthesiology and Pain Medicine, St. Mary's Hospital, The Catholic University of Korea College of Medicine) ;
  • Sung, Choon Ho (Department of Anesthesiology and Pain Medicine, St. Mary's Hospital, The Catholic University of Korea College of Medicine)
  • 김정학 (가톨릭대학교 의과대학 성모병원 마취통증의학교실) ;
  • 남복희 (가톨릭대학교 의과대학 성모병원 마취통증의학교실) ;
  • 문호식 (가톨릭대학교 의과대학 성모병원 마취통증의학교실) ;
  • 김진욱 (가톨릭대학교 의과대학 성모병원 마취통증의학교실) ;
  • 성춘호 (가톨릭대학교 의과대학 성모병원 마취통증의학교실)
  • Received : 2009.01.01
  • Accepted : 2009.01.14
  • Published : 2009.04.01
Download PDF
⟨ Previous Next ⟩

Abstract

Behcet's disease is a chronic relapsing vasculitis characterized by recurrent aphthous oral and genital ulcers with uveitis. Multiple organs can be involved. Entero-Behcet's disease is often uncontrollable, relapsing, and can cause acute intestinal bleeding, fistula formation, or perforation. Corticosteroids, immunosuppressors, and colchicines are used to treat Entero-Behcet's disease with varying degree of success. Thalidomide may also be feasible. We present a 29-year-old male Entero-Behcet's patient suffering from abdominal pain, diarrhea, and back pain. He did not respond to prior treatments, but responded to thalidomide.

Keywords

References

  1. Sakane T, Takeno M, Suzuki N, Inaba G: Behcet's disease. N Engl J Med 1999; 341: 1284-91 https://doi.org/10.1056/NEJM199910213411707
  2. Dilsen N: History and development of Behcet's disease. Rev Rhum Engl Ed 1996; 63: 512-9
  3. Yoshikawa K, Kotake S, Sasamoto Y, Ohno S, Matsuda H: Close association of Streptococcus sanguis and Behcet's disease. Nippon Ganka Gakkai Zasshi 1991; 95: 1261-7
  4. Eglin RP, Lehner T, Subak-Sharpe JH: Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behcet's syndrome and recurrent oral ulcers. Lancet 1982; 2: 1356-61 https://doi.org/10.1016/S0140-6736(82)91268-5
  5. Chang HK, Kim JU, Cheon KS, Chung HR, Lee KW, Lee IH: HLA-B51 and its allelic types in association with Behcet's disease and recurrent aphthous stomatitis in Korea. Clin Exp Rheumatol 2001; 19(Suppl): 31-5
  6. Kasahara Y, Tanaka S, Nishino M, Umemura H, Shiraha S, Kuyama T: Intestinal involvement in Behcet's disease:review of 136 surgical cases in the Japanese literature. Dis Colon Rectum 1981; 24: 103-6 https://doi.org/10.1007/BF02604297
  7. Whitehead R, Gratama S: Gastrointestinal and esophageal pathology. 2nd ed. New York, Churchill Livingstone. 1995, pp 687-709
  8. Kotter I, Durk H, Saal J, Fierlbeck G, Pleyer U, Ziehut M: Therapy of Behcet's disease. Ger J Ophthalmol 1996; 5: 92-7
  9. Pacor ML, Biasi D, Lunardi C, Cortina P, Caramaschi P, Girelli D, et al: Cyclosporin in Behcet's disease: results in 16 patients after 24 months of therapy. Clin Rheumatol 1994; 13: 224-7
  10. Sheskin J: Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther 1965; 6: 303-6 https://doi.org/10.1002/cpt196563303
  11. Saylan T, Saltik I: Thalidomide in the treatment of Behcet's syndrome. Arch Dermatol 1982; 118: 536 https://doi.org/10.1001/archderm.118.8.536
  12. Hamza MH: Treatment of Behcet's disease with thalidomide. Clin Rheumatol 1986; 5: 365-71 https://doi.org/10.1007/BF02054255
  13. Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G: Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med 1993; 177: 1675-80 https://doi.org/10.1084/jem.177.6.1675
  14. Suzuki Kurokawa M, Suzuki N: Behcet's disease. Clin Exp Med 2004; 4: 10-20 https://doi.org/10.1007/s10238-004-0033-4
  15. Houman MH, Hamzaoui K: Promising new therapies for Behcet's disease. Eur J Intern Med 2006; 17: 163-9 https://doi.org/10.1016/j.ejim.2005.11.011
  16. Chang HK: Treatment of Behcet's disease. J Korean Rheum Assoc 2003; 10: 101-10
  17. Larsson H: Treatment of severe colitis in Behcet's syndrome with thalidomide (CG-217). J Intern Med 1990; 228: 405-7 https://doi.org/10.1111/j.1365-2796.1990.tb00253.x
  18. Lee CK, Kim HJ: Pathogenesis and Treatment of Intestinal Behcet's disease. Korean J Gastroenterol 2007; 50: 3-8